- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03099018
Comparison of Two Rapid Antigen Detection Tests for the Detection of Group-A Streptococcal Pharyngitis in Children
April 13, 2017 updated by: Laurence Lacroix, University Hospital, Geneva
Group A streptococcal (GAS) pharyngitis in children represents a frequent diagnostic challenge in pediatric emergency departments, since isolated signs and clinical prediction rules are insufficient to accurately discriminate between GAS and non GAS infections.
Rapid antigen detection tests (RADTs) therefore remain essential, simple and rapid tools, allowing for rapid GAS identification and prompt antibiotic prescription.
However, their sensitivity is not optimal.
The aim of the present study is to test the accuracy of a new fluorescent immunoassay (Sofia Strep A FIA) using the optical technology for GAS detection in children 3-15 years old with pharyngitis, compared to a standard RADT, using throat culture as the gold standard (or PCR for discrepant results, i.e. negative culture with any positive RADT).
Study Overview
Study Type
Observational
Enrollment (Actual)
1000
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 15 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Children 3 to 15 years old presenting to the PED with pharyngitis and Mc Isaac score ≥ 2
Description
Inclusion Criteria:
- Patient age between 3 and 15 years
- Clinical diagnosis of pharyngitis
- McIsaac score ≥2
Exclusion Criteria:
- Antibiotic treatment in the two weeks preceding the consultation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnostic accuracy of the new Sofia Strep A FIA test in children with pharyngitis
Time Frame: 1 hour
|
Comparison of the sensitivity and specificity of two rapid tests (Sofia StrepA FIA and Alere Testpack Strep A) using standard throat culture as reference.
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnostic accuracy of the new Sofia Strep A FIA test in children with pharyngitis stratified on the pretest probability of GAS infection (according to McIsaac scores)
Time Frame: 1 hour
|
sensitivity and specificity of the two tests in relationship to the pretest-probability of GAS infection as measured by the McIsaac score
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Laurence Lacroix, MD, University Hospital, Geneva
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 1, 2014
Primary Completion (ACTUAL)
November 1, 2016
Study Completion (ACTUAL)
November 1, 2016
Study Registration Dates
First Submitted
March 28, 2017
First Submitted That Met QC Criteria
March 31, 2017
First Posted (ACTUAL)
April 4, 2017
Study Record Updates
Last Update Posted (ACTUAL)
April 17, 2017
Last Update Submitted That Met QC Criteria
April 13, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-248
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pharyngitis
-
Vastra Gotaland RegionGöteborg University; James Cook University, Queensland, AustraliaCompletedTonsillitis | Pharyngitis | Sore Throat | Streptococcus Pharyngitis | Pharyngitis BacterialSweden
-
Andrew SteerNational Health and Medical Research Council, Australia; Queen Fabiola Children... and other collaboratorsCompletedBacterial Infections | Gram-Positive Bacterial Infections | Strep Throat | Streptococcus Pharyngitis | Streptococcus Pyogenes Pharyngitis | Streptococcus Pyogenes Infection | Group A Streptococcus: B Hemolytic Pharyngitis | Group A Streptococcal InfectionAustralia
-
Luminex CorporationCompletedPharyngitis BacterialUnited States
-
Hamilton Health Sciences CorporationRecruiting
-
University of Wisconsin, MadisonNational Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
Dentaid SLMethodexRecruiting
-
Northwell HealthIcahn School of Medicine at Mount Sinai; Agency for Healthcare Research and...CompletedPneumonia | Strep PharyngitisUnited States
-
Oman Medical Speciality BoardCompleted
-
Megainpharm GmbHTerminated
-
Klara Posfay-BarbeGertrude Von Meissner Foundation; Recherche et Développement des HUG; Société...UnknownGroup A Streptococcal PharyngitisSwitzerland
Clinical Trials on Sofia Strep A FIA
-
University of Wisconsin, MadisonQuidel CorporationCompleted
-
Carilion ClinicTerminatedCovid-19United States
-
Quidel CorporationCompletedBorrelia; Infection, Burgdorferi (Erythema Chronicum Migrans)United States
-
Ellume Pty LtdCompletedInfluenza A | Influenza BAustralia
-
Luminex CorporationCompletedPharyngitis BacterialUnited States
-
Guangzhou Wondfo Biotech Co., LtdSuspended
-
University of Wisconsin, MadisonNational Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
University of British ColumbiaActive, not recruiting
-
University of Wisconsin, MadisonCompletedPneumonia | Influenza, Human